Helping develop the next life-saving therapy through Precision Medicine.
Enrollment of patients in clinical trials and continuing on-market studies can be a significant challenge, particularly in cases of rare disease. Ambry can help to overcome these hurdles with our patient identification programs, as well as providing quality assurance, project management, regulatory support and more for your clinical trial.
Leveraging customized genetic testing panels, expertise in variant interpretation, extensive field outreach, and a clinical research database of over 2.5 million tests, Ambry can develop a tailored program to meet your needs for patient identification and enrollment.
With extensive clinical trial expertise, robust quality management, and following GCLP (Good Clinical Laboratory Practice) standards, Ambry can streamline testing and raise patient/provider awareness, while delivering deep insights through comprehensive, customized reports.
Contact us to learn more about our AmbryLink sponsored testing programs.
Ambry is the expert in clinical trials. We provide the scientific, operational, and commercial support to streamline your study workflow, engage patients, and derive meaningful insights from the results.
We offer multiple test ordering modalities to lower barriers to testing, integrating into provider workflows via physical Test Requisition Forms, Ambry's online ordering portal, and EMR integration.
Ambry can also partner with you for commercial activities, including marketing outreach for patients and providers, field team engagement with providers, and other operational needs such as genetic counseling, test ordering/kit distribution, and program utilization reporting.
With scientific expertise and powerful in-house tools, Ambry can delve deep on every patient sample. We deliver cutting-edge analysis in detailed but easy-to-read reports, so that physicians can pass on the full power of the data to their patients.
Along with comprehensive reporting, Ambry also provides straightforward resources for patients to understand their test results and share information with family members who may also wish to be tested. We can share clinical trial opportunities with appropriate providers, explaining the relevance of the study and how their patients can learn more about trial enrollment.
We provide weekly or monthly data summaries to pharma partners on number of tests, number of ordering providers, positivity rates, and mutational profiles, so you are always kept informed of program status.